Comparison

Multiple Sclerosis [MS] vs MS 2024 Criteria

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

Multiple Sclerosis [MS]

This clinical decision support tool offers evidence-based medical content for healthcare professionals managing Multiple Sclerosis. It uses AI and natural language processing to provide quick, confident answers, improving patient care at the point of need.

Highlights
  • AI-powered clinical decision support
  • Voice-enabled natural language questions
  • Evidence-based, disease-specific content
  • Diagnosis, treatment, and care management topics
  • Case studies, videos, and interviews
  • Continuing medical education credit (CME/CE)
Features
Read full description

@Point of Care™ With Cognitive AI is a clinical decision-making mobile platform. Multiple Sclerosis @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care. With Cognitive AI, clinicians use @Point of Care to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Cognitive AI, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care. Multiple Sclerosis @Point of Care™ is designed to: • Support discovery and practice change • Provide relevant, evidence-based disease-specific medical content • Improve patient outcomes at the point of care Features: • Continually updated multiple sclerosis content • Topics in diagnosis, treatment, and care management developed with expert physician authors • Case studies, videos, and interviews • Access to actionable patient-recorded data • Detailed reference list with access to original sources • Continuing medical education credit (CME/CE) • Surveys and peer polling • Patient education resources to share with patients

About

MS 2024 Criteria

Features
Read full description

This app helps clinicians apply the McDonald Criteria 2024 for Multiple Sclerosis diagnosis through a structured, step-by-step approach. Designed for neurologists, residents, medical students and healthcare professionals, it transforms complex criteria into clear clinical decisions.

Screenshots

Multiple Sclerosis [MS]4 screens
MS 2024 Criteria4 screens

Verdict

The call

The clearest difference is price: Multiple Sclerosis [MS] at Free against MS 2024 Criteria's $1.99. On ads, in-app purchases, device support and iOS requirement there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Multiple Sclerosis [MS] is free to download; MS 2024 Criteria costs $1.99 up front. Neither carries in-app purchases, so what you see is what you pay.

Scorecard1 real difference · 9 level
Multiple Sclerosis [MS] versus MS 2024 Criteria: the parameters behind the verdict, then further details
ParameterMultiple Sclerosis [MS]MS 2024 Criteria
PriceFree — better$1.99
Rating5.0 (1 ratings) — better—
Positive reviews61.5% of reviews—
Number of ratings1 — better—
Update frequencyEvery 5 weeks—
AdsNoNo
In-app purchasesNoNo
MonetizationFree—
DevicesiPhone, iPad, iPodiPhone, iPad, iPod
Requires iOS14.0 — better15.1
Further details — not scored
Size22 MB194 MB
Age rating12+17+
Developer@Point of CareJean Martin Boulanger

In-app purchases

None

Multiple Sclerosis [MS]

No in-app purchases

None

MS 2024 Criteria

No in-app purchases

Questions

Is Multiple Sclerosis [MS] free?
Multiple Sclerosis [MS] is free to download, with no in-app purchases.
Is MS 2024 Criteria free?
MS 2024 Criteria costs $1.99, with no in-app purchases.
Do Multiple Sclerosis [MS] or MS 2024 Criteria have ads?
Neither Multiple Sclerosis [MS] nor MS 2024 Criteria shows ads.

Other comparisons